Suppr超能文献

支气管镜介入治疗严重肺气肿:我们现在在哪里?

Bronchoscopic interventions for severe emphysema: Where are we now?

机构信息

Department of Respiratory Medicine, Royal Brompton Hospital, London, UK.

National Heart and Lung Institute, Imperial College, London, UK.

出版信息

Respirology. 2020 Sep;25(9):972-980. doi: 10.1111/resp.13835. Epub 2020 May 3.

Abstract

Patients with severe emphysema have limited treatment options and only derive a small benefit from optimal medical treatment. The only other therapy to have significant clinical beneficial effect in emphysema is LVRS but the perceived risk and invasiveness of surgery has fuelled bronchoscopic approaches to induce lung volume reduction. There are multiple bronchoscopic methods for achieving volume reduction in severe emphysema: EBV, airway bypass procedure, endobronchial coils, thermal (vapour) sclerosis and chemical sclerosis (sealants). Optimal patient selection is key to successful patient outcomes. This review discusses bronchoscopic approaches for emphysema treatment which has progressed through clinical trials to clinical practice.

摘要

严重肺气肿患者的治疗选择有限,即使接受最佳的药物治疗,也只能获得很小的益处。在肺气肿中,唯一具有显著临床获益的其他治疗方法是 LVRS,但手术的风险和侵袭性促使人们寻求支气管镜介入来实现肺减容。有多种支气管镜方法可用于治疗严重肺气肿:EBV、气道旁路手术、支气管内线圈、热(蒸汽)硬化和化学硬化(密封剂)。最佳的患者选择是获得成功治疗结果的关键。本综述讨论了肺气肿治疗的支气管镜方法,该方法已通过临床试验进展到临床实践。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验